30 January 2026 : Review article
Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A Review
Yuxia Zuo BCE 1, Xingchao Xu BC 2, Cai Wu E 2, Xue Cui CE 2, Xiangqi Li A 2*DOI: 10.12659/MSM.951283
Med Sci Monit 2026; 32:e951283
Table 1 Analysis of direct and indirect sonographic features of chemotherapy-induced peripheral neuropathy (CIPN).
| Direct ultrasonic signs | Indirect ultrasonic signs |
|---|---|
| Alterations in Nerve Continuity, Complete Rupture: Disruption of nerve fascicle echogenicity with retracted ends/traumatic neuroma formation.Partial Tear: Localized architectural disorganization accompanied by hematoma | Peripheral Tissue Abnormalities, Compressive Lesions: Ganglion cysts (anechoic cystic structures), osteophytic deformities.Subsequent Changes: Edema (hypoechoic areas), fibrosis (hyperechoic enhancement) |
| Neuromorphological Alterations, Pathological thickening (eg, cross-sectional area [CSA] of the median nerve >10–15 mm in carpal tunnel syndrome). Chronic atrophy (thinning with hyperechoic fibrotic changes) | Muscle Denervation Changes, Acute phase: Muscle fascicle edema (hypoechoic and loss of fascicular architecture).Chronic phase: Atrophy with fatty infiltration (hyperechoic appearance and thickening of perimysial septa) |
| Microstructural Changes in Nerve Fascicles, Acute phase:Loss of fascicular demarcation and heterogeneous echotexture. Chronic phase: Structural disintegration with fibrosis (disruption of the normal “honeycomb” or “cable-like” architecture) | Dynamic Functional Impairments Abnormal nerve gliding (eg, gliding distance <3 mm in carpal tunnel syndrome), Compression-induced deformation (morphological changes at the site of constriction during dynamic observation) |
| CIPN – chemotherapy-induced peripheral neuropathy; CSA – cross-sectional area. | |






